The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine

BACKGROUND: Use of the antipsychotic drug olanzapine by patients with schizophrenia is associated with autonomic nervous system (ANS) dysfunction. It is presumed that there are interindividual differences in ANS dysfunction that correspond to pharmacogenetics. In this study, we investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Saki, Suda, Akira, Miyauchi, Masatoshi, Shiraishi, Yohko, Saeki, Takashi, Fukushima, Tadashi, Fujibayashi, Mami, Tsujita, Natsuki, Ishii, Chie, Ishii, Norio, Moritani, Tosiho, Saigusa, Yusuke, Kishida, Ikuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027321/
https://www.ncbi.nlm.nih.gov/pubmed/32070304
http://dx.doi.org/10.1186/s12888-020-02492-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027321/
https://www.ncbi.nlm.nih.gov/pubmed/32070304
http://dx.doi.org/10.1186/s12888-020-02492-5

Ejemplares similares